Q Holding Company appoints Thomas J. Hook as CEO
News | September 7, 2017
TWINSBURG, OH, September 2017 – Q Holding Company (“Q” or “the Company”) announced today that Thomas J. Hook has joined the Company as Chief Executive Officer to lead Q through its next phase of growth.
Tom brings extensive operational experience across multiple industries, most recently in the Medical Technology Markets. Prior to joining Q, he was President & CEO of Integer Holdings Corporation, the largest medical device outsource (MDO) manufacturer in the world. Integer’s brands include Greatbatch, Lake Region Medical, and Electrochem.
Cary Glay, Interim CEO and Executive VP & CFO, Q Holding, commented:
“We look forward to welcoming Tom as CEO. Q will strongly benefit from his deep knowledge and experience in the healthcare and industrial markets as the organization continues to focus on expanding each of its business lines. He also has extensive experience in building and integrating companies, which makes him well suited to lead Q at this time. Under Tom’s leadership, Integer grew from a $200 million to a $1.4 billion revenue business through a combination of very strong organic and acquisitive growth. We feel his expertise will be of great value in supporting Q’s future growth.”
Richard Relyea, Managing Director 3i North America, investor in Q Holding, added:
“We are excited to be partnering with Tom to continue to build Q. We are confident that under his leadership, the Company will further advance its position as the leading global supplier of highly engineered elastomeric components and devices for the high growth healthcare and electrical management markets.”
Thomas Hook, CEO, Q Holding, commented:
“It is a distinct honor to join Q Holding and lead the next phase of transformative growth for the company. I am delighted to partner with both 3i and the Q leadership team to drive the Company’s strategic growth plans. Q’s extensive engineered materials and manufacturing capabilities provide a strong foundation to aggressively expand in the healthcare and industrial markets.”
Tom started his career as a Nuclear Engineer in the US Navy. His experience includes engineering & executive roles with Duracell, VanOwen Group, General Electric and CTI Molecular Imaging. He holds an MBA from Vanderbilt University, a Masters in Chemistry from the State University of New York at Buffalo and a BS in Chemistry and Mathematics from St. Bonaventure University.
